Search

Your search keyword '"Follath, Ferenc"' showing total 167 results
Start Over Author "Follath, Ferenc" Search Limiters Peer Reviewed
167 results on '"Follath, Ferenc"'

1. Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock Trial

Author

Thiele, Holger, Desch, Steffen, Zeymer, Uwe, Montalescot, Gilles, Piek, Jan J., Torremante, Patrizia, Meyer-Saraei, Roza, Tebbe, Ulrich, Wöhrle, Jochen, Pachinger, Otmar, Busch, Clemens, Pfeiffer, Nathalie, Neumer, Alexander, Schneider, Steffen, Ouarrak, Taoufik, Reimer, Thomas, Lober, Christiane, Clemmensen, Peter, Follath, Ferenc, Wegscheider, Karl, Barthélémy, O., Zeitouni, M., Overtchouk, P., Guedeney, P., Hage, G., Hauguel-Moreau, Zeitouni, Michel, Akin, Ibrahim, Barthélémy, Olivier, Brugier, Delphine, Collet, Jean-Philippe, de Waha-Thiele, Suzanne, Greenwood, John P., Guedeney, Paul, Hage, Georges, Hauguel-Moreau, Marie, Huber, Kurt, Kerneis, Mathieu, Noc, Marko, Oldroyd, Keith G., Rouanet, Stéphanie, Savonitto, Stefano, Serpytis, Pranas, Silvain, Johanne, Stepinska, Janina, Vicaut, Eric, Vrints, Christiaan J.M., and Windecker, Stephan

Published
2021
Full Text
View/download PDF

3. Levosimendan: Molecular mechanisms and clinical implications: Consensus of experts on the mechanisms of action of levosimendan

Author

Papp, Zoltán, Édes, István, Fruhwald, Sonja, De Hert, Stefan G., Salmenperä, Markku, Leppikangas, Heli, Mebazaa, Alexandre, Landoni, Giovanni, Grossini, Elena, Caimmi, Philippe, Morelli, Andrea, Guarracino, Fabio, Schwinger, Robert H.G., Meyer, Sven, Algotsson, Lars, Wikström, Bernt Gerhard, Jörgensen, Kirsten, Filippatos, Gerasimos, Parissis, John T., González, Martín J. García, Parkhomenko, Alexander, Yilmaz, Mehmet Birhan, Kivikko, Matti, Pollesello, Piero, and Follath, Ferenc

Published
2012
Full Text
View/download PDF

6. Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity

Author

Parissis, John T., Andreoli, Chiara, Kadoglou, Nikolaos, Ikonomidis, Ignatios, Farmakis, Dimitrios, Dimopoulou, Ioanna, Iliodromitis, Efstathios, Anastasiou-Nana, Maria, Lainscak, Mitja, Ambrosio, Giussepe, Mebazaa, Alexandre, Filippatos, Gerasimos, and Follath, Ferenc

Published
2014
Full Text
View/download PDF

11. Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial

Author

Düngen, Hans-Dirk, Apostolović, Svetlana, Inkrot, Simone, Tahirović, Elvis, Krackhardt, Florian, Pavlović, Milan, Putniković, Biljana, Lainščak, Mitja, Gelbrich, Götz, Edelmann, Frank, Wachter, Rolf, Eschenhagen, Thomas, Waagstein, Finn, Follath, Ferenc, Rauchhaus, Mathias, Haverkamp, Wilhelm, Osterziel, Karl-Josef, Dietz, Rainer, and on behalf of the CIBIS-ELD investigators, subproject “Multicenter Trials” in the Competence Network Heart Failure

Published
2008
Full Text
View/download PDF

21. Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial

Author

Castagno, Davide, Jhund, Pardeep S., McMurray, John J.V., Lewsey, James D., Erdmann, Erland, Zannad, Faiez, Remme, Willem J., Lopez-Sendon, José L., Lechat, Philippe, Follath, Ferenc, Höglund, Christer, Mareev, Viacheslav, Sadowski, Zygmunt, Seabra-Gomes, Ricardo J., and Dargie, Henry J.

Published
2010
Full Text
View/download PDF

22. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine

Author

Gheorghiade, Mihai, Follath, Ferenc, Ponikowski, Piotr, Barsuk, Jeffrey H., Blair, John E.A., Cleland, John G., Dickstein, Kenneth, Drazner, Mark H., Fonarow, Gregg C., Jaarsma, Tiny, Jondeau, Guillaume, Sendon, Jose Lopez, Mebazaa, Alexander, Metra, Marco, Nieminen, Markku, Pang, Peter S., Seferovic, Petar, Stevenson, Lynne W., van Veldhuisen, Dirk J., Zannad, Faiez, Anker, Stefan D., Rhodes, Andrew, McMurray, John J.V., and Filippatos, Gerasimos

Published
2010
Full Text
View/download PDF

27. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

Author

Dickstein, Kenneth, Cohen-Solal, Alain, Filippatos, Gerasimos, McMurray, John J.V., Ponikowski, Piotr, Poole-Wilson, Philip Alexander, Strömberg, Anna, van Veldhuisen, Dirk J., Atar, Dan, Hoes, Arno W., Keren, Andre, Mebazaa, Alexandre, Nieminen, Markku, Priori, Silvia Giuliana, Swedberg, Karl, Vahanian, Alec, Camm, John, De Caterina, Raffaele, Dean, Veronica, Dickstein, Kenneth, Funck-Brentano, Christian, Hellemans, Irene, Kristensen, Steen Dalby, McGregor, Keith, Sechtem, Udo, Silber, Sigmund, Tendera, Michal, Widimsky, Petr, Zamorano, Jose Luis, Tendera, Michal, Auricchio, Angelo, Bax, Jeroen, Böhm, Michael, Corrà, Ugo, della Bella, Paolo, Elliott, Perry M., Follath, Ferenc, Gheorghiade, Mihai, Hasin, Yonathan, Hernborg, Anders, Jaarsma, Tiny, Komajda, Michel, Kornowski, Ran, Piepoli, Massimo, Prendergast, Bernard, Tavazzi, Luigi, Vachiery, Jean-Luc, Verheugt, Freek W. A., and Zannad, Faiez

Published
2008

49. Body mass index in acute heart failure: association with clinical profile, therapeutic management and in-hospital outcome.

Author

Parissis, John, Farmakis, Dimitrios, Kadoglou, Nikolaos, Ikonomidis, Ignatios, Fountoulaki, Ekaterini, Hatziagelaki, Erifili, Deftereos, Spyridon, Follath, Ferenc, Mebazaa, Alexandre, Lekakis, John, and Filippatos, Gerasimos

Subjects
BODY mass index, HEART failure, CLINICAL trials, HEALTH outcome assessment, HOSPITAL admission & discharge, HEART failure treatment, COMPARATIVE studies, RESEARCH methodology, MEDICAL cooperation, OBESITY, PROGNOSIS, QUESTIONNAIRES, RESEARCH, COMORBIDITY, EVALUATION research, RETROSPECTIVE studies, ACUTE diseases, HOSPITAL mortality, DIAGNOSIS
Abstract

Background: Increased body mass index (BMI) is a risk factor for heart failure, but evidence regarding BMI in acute heart failure (AHF) remains inconclusive. We sought to compare the clinical profile, treatment and in-hospital outcome across BMI categories in a large international AHF cohort.Methods: The Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) is a retrospective survey on 4953 patients admitted for AHF from nine countries in Europe, Latin America, and Australia. Patients with unavailable BMI data or BMI <18.5 kg/m(2) were excluded. Clinical data and in-hospital mortality were compared among the following BMI categories: 18.5-24.9 kg/m(2) (normal weight), 25-29.9 kg/m(2) (overweight) and ≥30 kg/m(2) (obese).Results: Overweight/obese patients represented 75.7% of patients and had worse New York Heart Association class (P < 0.001) and higher admission systolic blood pressure (P < 0.001). The prevalence of comorbidities increased in parallel with BMI and included arterial hypertension, diabetes mellitus, dyslipidaemia (all P < 0.001), chronic obstructive pulmonary disease (P = 0.041) and chronic kidney disease (P = 0.056). Use of guideline-recommended medications also increased in parallel with BMI (angiotensin converting enzyme inhibitors/angiotensin II receptor blockers, P < 0.001; β-blockers P < 0.001; mineralocorticoid receptors antagonist, P = 0.002). In-hospital mortality had a U-shaped relationship with BMI, with overweight patients having significantly lower rate (log-rank P = 0.027); this relationship vanished after adjustment for confounders.Conclusions: Overweight/obese patients represented the vast majority of AHF cases, had a higher prevalence of non-cardiovascular comorbidities and were more likely to receive guideline-recommended medications. The U-shaped relationship between in-hospital mortality and BMI may be explained by differences in clinical profile and treatment and not by an effect of body composition per se. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

50. Kardiovaskuläre Medikamente bei alten und multimorbiden Patienten.

Author

Follath, Ferenc

Abstract

Cardiovascular diseases, such as arterial hypertension, heart failure, coronary artery disease, peripheral circulatory problems and atrial fibrillation are increasingly present in aged patients. Comorbidities, mainly diabetes, renal dysfunction, chronic bronchitis and degenerative joint diseases, are also frequent and need additional drug treatment. The usual polypharmacy often causes side effects due to overdosage and/or drug interactions. The main difficulty in choosing the proper therapeutic regimen consists in the lack of suitable dosing guidelines with adapted therapeutic targets for the older multimorbid population, usually not represented in the large controlled trials forming the basis of general recommendations. European guidelines for hypertension and heart failure are discussed as examples. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results